Our Mission

We are dedicated to advancing access to numerous technological innovations, elevating the quality, rigor, and reliability of clinical research rooted in the scientific method.

Our commitment is to be instrumental in accelerating drug development, supporting pharmaceutical and biotechnology companies to bring therapies to patients swiftly and efficiently.

Our Purpose

We aspire to be catalysts of scientific knowledge, harnessing the transformative capabilities of technology and AI to propel clinical research advancements for the greater benefit of all.

Origins

Born from a rich legacy of leading visionaries in oncology, Science4Tech’s journey is a testament to their relentless pursuit of innovation in clinical research.

Steeped in a profound understanding of the field, we identified gaps and inefficiencies that begged for transformative solutions.

Today

Science4Tech, is a catalyst for change in clinical research.

We leverage technology and artificial intelligence to accelerate research and the development of new treatments

The Transition

Fuelled by a commitment to advancing healthcare, Science4Tech emerged as the asnwer – a dynamic spin-off company poised at the intersection of cutting-edge technology and clinical excellence.

Our roots in oncology research provide us with a unique vantage point, allowing us to pinpoint challenges and redefine possibilities.

Our Mission

We are dedicated to advancing access to numerous technological innovations, elevating the quality, rigor, and reliability of clinical research rooted in the scientific method.

Our commitment is to be instrumental in accelerating drug development, supporting pharmaceutical and biotechnology companies to bring therapies to patients swiftly and efficiently.

Recognizing the lack of efficiency in clinical trials, we decided to take a bold turn.

We’re eager to shape the future of digital clinical trials.

The Opportunity

In the ever-evolving landscape of clinical trials, we saw an opportunity to revolutionize the approach.

With a vision to optimize and accelerate the drug development process, we harnessed the power of data and artificial intelligence.

Our Purpose

We aspire to be catalysts of scientific knowledge, harnessing the transformative capabilities of technology and AI to propel clinical research advancements for the greater benefit of all.

Origins

Born from a rich legacy of leading visionaries in oncology, Science4Tech’s journey is a testament to their relentless pursuit of innovation in clinical research.

Steeped in a profound understanding of the field, we identified gaps and inefficiencies that begged for transformative solutions.

The Transition

Fuelled by a commitment to advancing healthcare, Science4Tech emerged as the asnwer – a dynamic spin-off company poised at the intersection of cutting-edge technology and clinical excellence.

Our roots in oncology research provide us with a unique vantage point, allowing us to pinpoint challenges and redefine possibilities.

Recognizing the lack of efficiency in clinical trials, we decided to take a bold turn.

The Opportunity

In the ever-evolving landscape of clinical trials, we saw an opportunity to revolutionize the approach.

With a vision to optimize and accelerate the drug development process, we harnessed the power of data and artificial intelligence.

Today

Science4Tech, is a catalyst for change in clinical research.

We leverage technology and artificial intelligence to accelerate research and the development of new treatments

Our Mission

We are dedicated to advancing access to numerous technological innovations, elevating the quality, rigor, and reliability of clinical research rooted in the scientific method.

Our commitment is to be instrumental in accelerating drug development, supporting pharmaceutical and biotechnology companies to bring therapies to patients swiftly and efficiently.

We’re eager to shape the future of digital clinical trials.

Our Purpose

We aspire to be catalysts of scientific knowledge, harnessing the transformative capabilities of technology and AI to propel clinical research advancements for the greater benefit of all.

Transition
2012 2019

Founders

María Campos, MPharm
toggle description

María Campos, MPharm

Founder

Dr. Javier Cortés, PhD
toggle description

Dr. Javier Cortés, PhD

Founder

Dr. Antonio Llombart, PhD
toggle description

Dr. Antonio Llombart, PhD

Founder

Executive Team

Jordi Guitart, PhD
toggle description

Jordi Guitart, PhD

Chief Executive Officer

Cris Masferrer, MPharm
toggle description

Cris Masferrer, MPharm

Chief Business Officer

Cristina Fernández, PhD
toggle description

Cristina Fernández, PhD

Chief Product & Innovation Officer

Blanca Sabater, MSc
toggle description

Blanca Sabater, MSc

Chief Financial Officer

Sergi Hernando, MSc
toggle description

Sergi Hernando, MSc

Chief Technology Officer

Case Studies

Real-time fulfillment of eCRF using generative AI

Our CapTrial solution revolutionized clinical trial data management by automating the process of extracting and transforming data from hospital EHR systems into the sponsor's eCRF. Utilizing NLP, ML, and DeepL, our technology significantly enhanced data precision and reliability, reducing the manual burden associated with traditional data transfer methods while maintaining traceability and explainability to ensure compliance with GCP guidelines.

Ensuring a highly qualified patient pool

Our MatchTrial app played a pivotal role in helping our pharmaceutical client achieve the recruitment of patients for a clinical trial targeting solid tumors with hepatic impairment. The recruitment was finished 5 months ahead of schedule. The app's innovative matching algorithm and targeted outreach, efficiently paired eligible patients with the clinical trial, saving the client significant time and resources in the recruitment process, and leading to a screening failure below 5% at the recruitment site.

Designing the PALMIRA trial

When designing the PALMIRA trial, our client chose our NexTrial solution (formerly Conan) to validate their initial site pre-selection across EU Big 5 countries. NexTrial anticipated overall successful recruitment rates, with Spain contributing 55% of recruiting sites. 

PHERGain, a complex multi-site trial

A complex international multi-site trial, such as PHERGain, used ParTrial to successfully address the challenge posed by the participation of 56 sites and 7 countries, in a study with a screening process where the results of critical tests, such as centralized confirmation of HER2 status and centralized review of 18F-FDG PET/CT, had to be delivered within very limited timeframes and managed by many different teams.

Welcome to the future of healthcare innovation!

At Science4Tech, we are on a mission to revolutionize the world of Clinical Trials by leveraging cutting-edge technology to accelerate the development of life-changing therapies. If you’re passionate about making a real impact in the healthcare industry, pushing the boundaries of what’s possible, and driving progress in clinical research, you’ve come to the right place.

We are a a dynamic and forward-thinking team who believes in the power of technology to transform the way Clinical Trials are conducted, ultimately bringing new hope to patients around the world. Whether you’re a software engineer, data scientist, project manager, or a creative mind with a passion for healthcare, we’re always on the lookout for top talent to help us drive our mission forward.

Explore our open positions, learn more about our culture of innovation, and discover how you can be a part of this incredible journey to reshape the future of Clinical Trials.

Do you want to work with us?

View Careers

    Let’s talk